External resources NEJM Phase 2 Trial: Triple Hormone Receptor Agonist Retatrutide for Obesity PMC Review: Retatrutide - A Game Changer in Obesity Pharmacotherapy ClinicalTrials.gov: Retatrutide TRIUMPH Clinical Trial Registry Nature Medicine: Retatrutide for Metabolic Dysfunction-Associated Steatotic Liver Disease For researchers serious about optimizing their retatrutide protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, personalized protocol builders, dosing calculators, and a community of thousands who have navigated these exact questions
Currently, no FDA-approved BPC-157 products exist for human use, making all available formulations research compounds or compounded preparations from licensed pharmacies
Half-life Not established in humans no published human pharmacokinetic study exists
Very happy, should build out an entire peptide line
While absorption rates may vary between oral and injectable forms, many prefer oral BPC-157 for its convenience, ease of use, and ability to fit into a daily supplement stack
